ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,321.41
0.25%
Dow Jones
39,872.99
0.17%
US Dollar vs MXN
16.60845
-0.08%
Brent Oil
81.53
-1.11%
Bitcoin
69,718.06
-0.59%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Accelerate Diagnostics Inc (AXDX)

  7. Accelerate Diagnostics Inc (AXDX) Noticias

AXDX

Accelerate Diagnostics (AXDX)

Accelerate Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AXDX
FechaHoraFuenteTítuloSímboloCompañía
21/05/202418:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXDXAccelerate Diagnostics Inc
13/05/202415:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXDXAccelerate Diagnostics Inc
10/05/202416:24Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
08/05/202415:42PR Newswire (US)Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
02/05/202408:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
28/03/202415:05PR Newswire (US)Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
07/03/202408:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.NASDAQ:AXDXAccelerate Diagnostics Inc
05/03/202414:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXDXAccelerate Diagnostics Inc
22/01/202420:59Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:AXDXAccelerate Diagnostics Inc
21/01/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AXDXAccelerate Diagnostics Inc
19/01/202408:20PR Newswire (US)Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private PlacementNASDAQ:AXDXAccelerate Diagnostics Inc
18/01/202406:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
16/01/202406:45PR Newswire (US)Accelerate Diagnostics Announces Launch of Proposed Public OfferingNASDAQ:AXDXAccelerate Diagnostics Inc
07/01/202419:00PR Newswire (US)Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
13/12/202316:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AXDXAccelerate Diagnostics Inc
27/11/202308:15PR Newswire (US)Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202316:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXDXAccelerate Diagnostics Inc
09/11/202315:05PR Newswire (US)Accelerate Diagnostics Reports Third Quarter 2023 ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
30/10/202308:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Third Quarter Results.NASDAQ:AXDXAccelerate Diagnostics Inc
10/08/202315:05PR Newswire (US)Accelerate Diagnostics Reports Second Quarter 2023 Financial ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
27/07/202308:30PR Newswire (US)Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter ResultsNASDAQ:AXDXAccelerate Diagnostics Inc
10/07/202319:04Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXDXAccelerate Diagnostics Inc
10/07/202308:00PR Newswire (US)Accelerate Diagnostics Announces 1-for-10 Reverse Stock SplitNASDAQ:AXDXAccelerate Diagnostics Inc
29/06/202317:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AXDXAccelerate Diagnostics Inc
21/06/202305:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AXDXAccelerate Diagnostics Inc
20/06/202316:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202309:57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AXDXAccelerate Diagnostics Inc
13/06/202308:00PR Newswire (US)Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform WaveNASDAQ:AXDXAccelerate Diagnostics Inc
01/06/202317:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AXDXAccelerate Diagnostics Inc
31/05/202315:11Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:AXDXAccelerate Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:AXDX

Su Consulta Reciente

FX
USDMXN
US Dollar vs MXN
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NYSE
MRK
Merck
FX
EURMXN
Euro vs MXN
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
KO
Coca Cola
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados